Mark C. Fishman

Mark C. Fishman

Lead Independent DirectoratBeam Therapeutics· In proxies 2023–2025

Mark C. Fishman sits on 5 public boards.

Boards1

  • Beam TherapeuticsLead independent director · 7 yr on the boardIndependentNominating and Corporate Governance, Science and Technology (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Beam TherapeuticsPublic company · 3 yr
    • Lead Independent Director2023 – Present · 3 yrStock in role -24%
  2. Skyline TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  3. Versanis BioPublic company
    • Director? – PresentNo stock prices for these years
  4. Semma TherapeuticsPublic company · 10 yr
    • Director2016 – Present · 10 yrNo stock prices for these years
  5. Novartis International Pharmaceutical LTDPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?